CD4 and B-cell chronic lymphocytic leukemia: Another study by Smallwood et al. [25] elucidated the role of tumour (CLL)-derived EVs in promoting ME modification and immune evasion and angiogenesis, by studying the impact of such EVs on CD4+ T cells.